Credit Agricole’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-390
Closed -$102K – 690
2019
Q2
$102K Sell
390
-6,000
-94% -$1.59M 0.01% 344
2019
Q1
$1.82M Sell
6,390
-1,075
-14% -$357K 0.1% 209
2018
Q4
$2.43M Sell
7,465
-158
-2% -$54.9K 0.14% 188
2018
Q3
$3.43M Sell
7,623
-177
-2% -$69.8K 0.16% 160
2018
Q2
$3.19M Buy
7,800
+3,600
+86% +$1.3M 0.22% 103
2018
Q1
$1.22M Buy
+4,200
New +$1.06M 0.08% 190
2017
Q2
– Sell
-5,306
Closed -$664K – 1633
2017
Q1
$664K Buy
5,306
+4,081
+333% +$473K ﹤0.01% 1306
2016
Q4
$138K Hold
1,225
– – ﹤0.01% 1364
2016
Q3
$158K Hold
1,225
– – ﹤0.01% 1475
2016
Q2
$134K Buy
+1,225
New +$122K ﹤0.01% 1390

Other funds holding ABMD

Credit Agricole's ABMD Position: Q3 2019 in Review

Credit Agricole sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 390 shares — an estimated $102K sold.

Credit Agricole first reported a position in ABMD in Q2 2016 and held it in 10 quarters. The position peaked at $3.43M in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Credit Agricole reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Credit Agricole sold 390 Abiomed Inc shares in Q3 2019, an estimated $102K.
  • Credit Agricole first reported a position in Abiomed Inc in Q2 2016 and held it in 10 quarters.
  • Credit Agricole's Abiomed Inc position peaked at $3.43M in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Credit Agricole's 13F filing for Q3 2019, filed 8 Nov 2019.